جامعة المعرفة
المصدر المعتمد للمعلومات البحثية والمخرجات هو قاعدة بيانات سكوبس (Elsevier Scopus) مع تدقيق بيانات الباحثين من عمادة البحث العلمي.

Research outputs

المخرجات البحثية

مقالات ومراجعات وأوراق مؤتمرات وفصول كتب، مفهرسة برقم DOI ومربوطة بباحثي الجامعة.

87 مُخرَج نتائج البحث عن «Clinical trial»

مراجعةمفتوح (مستودع)202613استشهاد· Semantic Scholar

Anticancer Molecular Mechanisms of Curcuminoids: An Updated Review of Clinical Trials

Food Science & Nutrition · مجلد 14 (2) · e71452-e71452

(turmeric), and have received much attention due to their pleiotropic anticancer properties. Recent evidence suggests that curcumin and analogs prevent the activation of a variety of signaling pathways, including the MAPK, PI3K/Akt, and NF-kB pathways, resulting in the induction of apoptosis, prevention of proliferation, and suppression. In addition to these processes, curcumin has been shown to enhance the efficacy of the conventional anti-cancer modalities such as radiation and chemotherapy. By suppressing the expression of matrix metalloproteinases (MMPs), which are enzymes that break down the extracellular matrix and promote cancer cell invasion and metastasis, curcumin also demonstrates anti-metastatic qualities. Inflammation and the advancement of cancer are linked to the NF-κB signaling pathways, which are also suppressed by curcuminoids. Along with these processes, curcumin has demonstrated the ability to improve the effectiveness of traditional cancer treatments, including radiation and chemotherapy. It increases the sensitivity of cancer cells to various therapies, which enhances the therapeutic results. However, curcumin's low bioavailability limits its therapeutic use. Its anticancer potency may be increased, and this restriction may be overcome due to recent developments in drug delivery technologies, such as curcumin-loaded nanoparticles. Since they can target several different molecular pathways and improve the effectiveness of current treatments, curcuminoids are a promising family of chemicals for the prevention and treatment of cancer.

curcuminoidscurcuminanticancer mechanismMAPK signaling
مراجعةوصول مفتوح20263استشهاد· Semantic Scholar

Polynucleotides and Polydeoxyribonucleotides for Skin Rejuvenation, Postoperative Scar Prevention, and Wound Healing: A Systematic Review of Randomized Clinical Trials

Cureus · مجلد 18 (7) · e112403-e112403

Polynucleotides (PNs) and polydeoxyribonucleotides (PDRNs) are increasingly used in regenerative dermatology; however, randomized evidence across skin rejuvenation, scar prevention, and wound healing has not been comprehensively synthesized. This systematic review evaluated randomized clinical trials investigating PN- and PDRN-based interventions in these indications. PubMed, Embase, and the Cochrane Central Register of Controlled Trials (CENTRAL) were searched through January 2026. Seven randomized trials involving 183 participants met the inclusion criteria. Four studies evaluated skin rejuvenation, one postoperative scar prevention, and two wound-healing applications. Across studies, PN and PDRN therapies improved wrinkle-related outcomes, scar quality, wound-healing metrics, and patient-reported satisfaction. The most consistent benefits were observed in wound-healing settings, where PDRN accelerated re-epithelialization and shortened healing time compared with controls. No serious treatment-related adverse events were reported. Although findings support the regenerative potential of PN- and PDRN-based therapies across multiple dermatologic applications, the evidence base remains limited by small sample sizes, heterogeneous treatment protocols, and variable outcome measures. Larger, adequately powered randomized trials are needed to establish optimal clinical indications and treatment strategies.

polynucleotidespolydeoxyribonucleotideskin rejuvenationwound healing
مقالوصول مفتوح20262استشهاد· Semantic Scholar

High-intensity versus low-intensity laser acupuncture in chronic, non-specific low back pain: a double-blinded, randomized controlled trial

Frontiers in Medicine · مجلد 13 · 1857622-1857622

Background: Chronic nonspecific low back pain (CNSLBP) is a musculoskeletal condition characterized by persistent discomfort, weak trunk muscles, exhaustion, and disability. Objectives: The purpose of this study is to compare the effects of high-intensity laser acupuncture (HILA) and low-intensity laser acupuncture (LILA), combined with exercise, on strength of trunk extensors, fatigue, level of pain, range of motion (ROM) of lumbar flexion, and disability in patients with CNSLBP. Materials and methods: 60 participants with CNSLBP were divided into three groups in this randomized, double-blind, sham-controlled trial: the high-intensity laser (HILA) group, who received HILA over 15 acupuncture points along with exercises; the low-intensity laser (LILA) group, who received LILA over the same points plus exercises; and the sham group, who received sham laser in addition to exercises. The interventions were received three times/week for four consecutive weeks. The strength of trunk extensors, fatigue, pain, lumbar flexion ROM, and disability were measured at baseline, after 4 weeks, and at a 1-month follow-up. The assessment tools used included isokinetic dynamometry, the visual analogue scale (VAS), the modified Schober test (MST), and the Oswestry Disability Index (ODI). Results: < 0.05). However, fatigue and disability did not differ between the two active laser groups. All groups showed minor changes between the post-treatment and follow-up periods. Conclusion: Patients with CNSLBP may have a short-term benefit from HILA and LILA combined with exercise rather than from exercise alone in terms of trunk extensor strength and fatigue, pain, lumbar flexion ROM, and disability. However, both laser treatments showed comparable effects on fatigue and disability; HILA appears to be more effective than LILA in improving trunk extensor strength and relieving pain. To define the ideal treatment parameters and to evaluate long-term effects, further research is required. Clinical Trial Registration: https://clinicaltrials.gov/, identifier [NCT06280846].

chronic non-specific low back painlaser acupunctureexercise therapytrunk extensor strength
مقالوصول مفتوح20261استشهاد· Semantic Scholar

GLP-1 receptor agonists as potential disease-modifying agents in Parkinson’s and Alzheimer’s disease: mechanisms, clinical trial evidence, and the neuroprotection horizon

Frontiers in Aging Neuroscience · مجلد 18

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), originally developed as antidiabetic agents, have emerged as candidate disease-modifying therapies for Parkinson’s disease (PD) and Alzheimer’s disease (AD), reflecting the widespread expression of GLP-1 receptors across neurons, glia, and the cerebral vasculature. This narrative review synthesizes mechanistic, clinical trial, and biomarker evidence for GLP-1 RAs in PD and AD, based on a literature search of PubMed, Embase, Scopus, and Web of Science, with ClinicalTrials.gov searched separately for trial protocols and results, through May 2026. Preclinical data implicate GLP-1 receptor agonism in anti-neuroinflammatory signaling, mitochondrial preservation, autophagy and proteostasis enhancement, anti-apoptotic effects, synaptic plasticity, cerebrovascular protection, and glymphatic clearance. Clinical evidence in PD is mixed and agent- and formulation-dependent: the phase II Exenatide-PD trial reported a motor benefit that persisted after washout (∼3.5-point between-group difference in MDS-UPDRS Part III), and the phase II LIXIPARK trial (lixisenatide) reported a significant 3.08-point between-group difference (95% CI 0.86–5.30; p = 0.007) favoring lixisenatide, whereas the larger, longer phase III Exenatide-PD3 trial, using an extended-release weekly formulation, found no significant effect on the same endpoint (adjusted coefficient 0.92; 95% CI −1.56 to 3.39; p = 0.47); oral semaglutide is under investigation in the ongoing phase II MOST-ABLE trial. In AD, the phase IIb liraglutide (ELAD) trial did not achieve statistical benefit on either its primary imaging endpoint (cerebral glucose metabolic rate; p = 0.14) or on most secondary cognitive measures, and the phase III semaglutide trials EVOKE and EVOKE+ did not meet their primary CDR-SB endpoint (estimated difference −0.08, 95% CI −0.35 to 0.20, p = 0.57 in EVOKE; 0.10, 95% CI −0.17 to 0.38, p = 0.46 in EVOKE+), despite biomarker signals including reductions in cerebrospinal fluid tau species and inflammatory markers. Comparative pharmacology reveals substantial heterogeneity in central nervous system penetration, receptor engagement, and systemic bioavailability across exenatide, liraglutide, semaglutide, and the imbalanced GLP-1/GIP co-agonist tirzepatide, complicating cross-agent extrapolation. Persistent challenges include separating direct neuroprotection from indirect metabolic and cardiovascular benefit, limited characterization of brain drug exposure, trial durations that may be short relative to the expected latency of a disease-modifying effect, and the absence of validated response biomarkers. We conclude that although the mechanistic and epidemiological rationale for GLP-1 RAs in neurodegeneration remains biologically plausible, current trial evidence does not yet support their use outside clinical trials, irrespective of comorbid diabetes status; future studies should prioritize earlier intervention, biomarker-guided patient selection, adequately powered subgroup analyses, and brain-penetrant formulations.

GLP-1 receptor agonistsParkinson's diseaseAlzheimer's diseasedisease-modifying therapy
مقالوصول مفتوح20261استشهاد· Semantic Scholar

Climate change literacy and environmental stewardship in neonatal intensive care: a mixed-methods study of nursing practice patterns

BMC Nursing · مجلد 25 (1)

BACKGROUND: Healthcare produces ≈ 4.4% of global greenhouse-gas emissions, and Neonatal Intensive Care Units (NICUs) are among its most resource-intensive services. In Egypt, where material constraints intensify ecological strain, the climate-change literacy and stewardship practices of NICU nurses remain undocumented. AIM: To examine climate-change literacy levels, environmental-stewardship practices, and the factors that influence their implementation among NICU nurses in Egypt. DESIGN: Convergent parallel mixed-methods study (January – March 2024). METHODS: Ninety-five nurses from three NICUs completed the Climate, Health and Nursing Tool (CHANT). Quantitative data were analysed in SPSS v28 (descriptives, χ², Spearman ρ, multiple linear regression). Twenty-four purposively selected nurses were interviewed, and their transcripts were analyzed using reflexive thematic analysis in NVivo 12. Meta-inferences were generated through joint-display integration. RESULTS: Literacy was moderate (mean = 3.15 ± 0.89); climate awareness was higher (3.45 ± 0.82), while professional engagement lagged (2.87 ± 1.03). Prior environmental training (β = 0.35, p < 0.001) and NICU experience (β = 0.31, p < 0.001) predicted higher literacy (R² = 0.64). Stewardship behaviours differed by hospital type; for energy-efficient equipment use, χ² (2) = 8.94, p = 0.011, with the highest prevalence in general hospitals (75.7%). Qualitatively, nurses described stewardship as constrained by resource scarcity, time pressure, and unclear policy, and enabled by visible leadership, practical training, and supportive peer micro-cultures. CONCLUSION: Egyptian NICU nurses possess the knowledge base to champion sustainability; however, systemic constraints hinder their actions. Embedding mandatory environmental modules, visible managerial endorsement, and enforceable eco-policies is essential to convert literacy into low-carbon neonatal care. IMPLICATIONS FOR PRACTICE: The study provides administrators and educators with a data-driven blueprint for greening NICU operations without compromising neonatal outcomes, thereby advancing national climate commitments and Sustainable Development Goal 3. CLINICAL TRIAL NUMBER: Not applicable.

climate change literacyenvironmental stewardshipneonatal intensive careNICU nurses
مقالوصول مفتوح20261استشهاد· Semantic Scholar

Efficacy of combined Kinesio-taping with chest physiotherapy program on pain, pulmonary function, respiratory muscle strength and quality of life after mastectomy: a randomized controlled trial

Frontiers in Medicine · مجلد 12 · 1664210-1664210

Objectives This study aimed to assess the effects of incorporating Kinesio-taping (KT) into a chest physical therapy program on alleviating pain and enhancing pulmonary function, respiratory muscle strength, and quality of life following mastectomy. Design This was a prospective, randomized controlled trial. Setting Physiotherapy outpatient clinic. Participants Sixty participants aged 30–50 years who had undergone modified radical mastectomy were randomly allocated to either the Kinesio-taping or traditional physical therapy exercise group. Intervention The Kinesio-taping group received both Kinesio-taping and traditional chest physiotherapy. The control group received only the traditional chest physiotherapy program. The interventions were administered over a 4-week period. Outcome measures The primary outcome measure was pain, which was evaluated using a visual analogue scale (VAS). Secondary outcomes included pulmonary function, specifically forced vital capacity (FVC) and forced expiratory volume in one second (FEV1), assessed via spirometry; respiratory muscle strength, determined by measuring maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP) using a portable pressure device; and quality of life, assessed using the Short Form-36 (SF-36) questionnaire. All outcomes were measured at baseline and 4 weeks after the intervention. Results The evaluated parameters exhibited significant alterations between the pre- and post-intervention after a duration of 4 weeks in both groups. The results indicated a significant changes ( p < 0.001) in post-intervention measures compared to pre-intervention measures in both groups. No significant differences were observed between the groups before the intervention. The KT group demonstrated superior postintervention outcomes. Specifically, the KT group showed a significant reduction in VAS scores post-intervention than the control group (3.97 ± 1.65 vs. 6.50 ± 1.57, p < 0.001). Post-intervention, the KT group exhibited significantly higher values ( p < 0.001) of FVC, FEV1, and FEV1/FVC (3.52 ± 0.64 L, 2.95 ± 0.56 L, and 85.09 ± 12.07%) compared to the control group (2.38 ± 0.56 L, 1.74 ± 0.54 L, and 72.39 ± 10.82%), respectively. Additionally, post-intervention MIP and MEP values were significantly higher ( p < 0.001) in the KT group. Conclusion Integrating Kinesio-taping into a standard chest physiotherapy program significantly reduced pain and enhanced pulmonary function, respiratory muscle strength, and quality of life in post-mastectomy patients compared to the application of traditional chest physiotherapy alone. Clinical trial registration ClinicalTrials.gov , identifier NCT06701591.

kinesio tapingchest physiotherapymastectomypostoperative pain
مقالوصول مفتوح2026

Protracted Bacterial Bronchitis in Children: Clinical Presentation, Diagnostic Evaluation, and Evidence-Based Management

Cureus

Protracted bacterial bronchitis (PBB) is a treatable cause of chronic wet cough in children but is frequently missed.Unrecognized children often cycle through repeat asthma treatment, short antibiotic courses that do not address the infection, or open-ended reassurance without further evaluation.This review summarizes the clinical presentation, diagnostic criteria, differential diagnosis, treatment, and follow-up of PBB in children.We conducted a targeted narrative review (PubMed, through September 2026) of clinical trials, longitudinal studies, systematic reviews, and professional-society guidance, distinguishing evidence for antibiotic treatment from limited observational evidence linking recurrent PBB to bronchiectasis.Clinicians should suspect PBB in a child with a daily wet cough lasting more than four weeks and no findings indicating another cause.Resolution after an appropriate antibiotic course supports the diagnosis.Amoxicillinclavulanate remains the usual first-line treatment, typically for two weeks initially, with reassessment and selective extension to four weeks if the child has not cleared.Further investigation is warranted when symptoms persist despite adequate treatment, recurrence is frequent, or specific warning signs appear.In an otherwise typical, treatment-responsive case, bronchoscopy and chest computed tomography (CT) are not routine first steps.Management hinges on recognizing the wet-cough phenotype, giving an adequate therapeutic trial, confirming resolution, and investigating promptly when treatment fails.Antibiotics appear to improve cough resolution, but this rests on a small number of trials with limited certainty, and evidence that treatment itself prevents bronchiectasis remains thin.

protracted bacterial bronchitischronic wet coughpediatric respiratory infectionamoxicillin-clavulanic acid
مراجعةوصول مفتوح2026

Efficacy and Safety of Vernakalant for Cardioversion of Atrial Fibrillation and Flutter: A Systematic Review and Meta-Analysis

Journal of Clinical Medicine · مجلد 15 (19) · 7406-7406

Background/Objectives: Vernakalant is an atrial-selective antiarrhythmic used for rapid pharmacological cardioversion of recent-onset atrial fibrillation. This systematic review and meta-analysis evaluated the efficacy and safety of vernakalant compared with placebo, active antiarrhythmic therapy, and electrical cardioversion. Methods: PubMed, Embase, Google Scholar, and the Cochrane Central Register of Controlled Trials (CENTRAL) were searched from inception to August 2026. Randomized clinical trials, clinical trials, and comparative observational studies evaluating vernakalant in adults with atrial fibrillation or atrial flutter were included. Dichotomous outcomes were pooled as risk ratios (RRs) with 95% confidence intervals (CIs) using the Mantel–Haenszel random-effects model in RevMan 5.4. Results: Twenty controlled studies involving 4523 patients were included, of whom 2349 received vernakalant and 2174 received control therapy. Vernakalant significantly increased successful conversion to sinus rhythm compared with all controls (1234/2244 (55%) vs. 991/2147 (46.2%); RR = 1.63; 95% CI [1.34, 1.99]; p < 0.00001). The effect was strongest versus placebo (RR = 5.33; 95% CI [1.95, 14.60]; p = 0.001) and remained significant versus procainamide (111/178 (62.3%) vs. 83/172 (48.2%); RR = 1.29; 95% CI [1.07, 1.57]; p = 0.009) and flecainide (209/280 vs. 209/330 (63.3%); RR = 1.18; 95% CI [1.05, 1.33]; p = 0.007), but non-significant against amiodarone, propafenone, ibutilide, or electrical cardioversion. Safety outcomes did not differ significantly between groups, including all-cause mortality (RR = 1.23), drug discontinuation (RR = 0.98), serious adverse events (RR = 0.87), ventricular tachycardia (RR = 0.68), bradycardia (RR = 1.31), and hypotension (RR = 0.80). Conclusions: Vernakalant was associated with higher rates of conversion to sinus rhythm, while no statistically significant differences were observed in major safety outcomes. These findings support its use as a pharmacological option for rapid rhythm restoration in appropriately selected patients.

vernakalantatrial fibrillationatrial flutterpharmacological cardioversion
مقالوصول مفتوح2026

Effect of the multimodal vestibular training on balance and quality of life in stroke survivors: a randomized controlled trial

Scientific Reports

Post-stroke balance impairment is multifactorial, and limited evidence is available on whether Multimodal Vestibular Training (MVT) provides additional benefits when added to conventional balance training. This study investigated the effect of a four-week MVT program on balance, functional mobility, and quality of life in chronic stroke survivors. After screening 25 stroke patients, 21 eligible chronic stroke survivors were enrolled. Participants were aged 30–75 years, had stroke duration of at least six months, could walk at least 10 m safely under supervision, had MMSE scores ≥ 24, and had Berg Balance Scale scores > 21. Participants were randomly assigned to the experimental group ( n = 11), which received MVT with conventional balance training, or the control group ( n = 10), which received conventional balance training only. Both groups received three supervised 45-minute sessions per week for four weeks. Outcomes were assessed at baseline and post-intervention using the Timed Up and Go (TUG) test, Berg Balance Score (BBS), and Stroke-Specific Quality of Life questionnaire (SS-QoL). Eighteen participants completed the post-intervention assessment and were included in the final analysis, with nine participants in each group. No significant baseline differences were observed between groups. Post-intervention analysis showed significantly better TUG scores in the experimental group than the control group, ( p = 0.002), and significantly better SS-QoL scores ( p = 0.006). Post-intervention BBS scores did not differ significantly between groups ( p = 0.924). Change-score analysis showed significantly greater improvement in the experimental group for TUG ( p = 0.042), BBS ( p = 0.013), and SS-QoL ( p = 0.023). The findings suggest that MVT, when added to conventional rehabilitation, may be associated with improvements in functional mobility and selected quality-of-life outcomes in chronic stroke survivors. BBS scores improved over time, although the post-intervention between-group difference was not significant. Given the limited sample size and short intervention duration, these findings should be interpreted as preliminary and confirmed in larger adequately powered randomized controlled trials. Trial registration: The study protocol was prospectively registered online in the Clinical Trial Registry India (CTRI) at https//www.ctri.nic.in/ with the identifier CTRI/2023/12/060822 dated 18/12/2023.

chronic strokepost-stroke balance impairmentbalance trainingfunctional mobility
مراجعةوصول مفتوح2026

Effects of Transcranial Direct Current Stimulation Versus Sham Stimulation on Brain-Derived Neurotrophic Factor and Clinical Outcomes: A Systematic Review and Meta-Analysis

Journal of Clinical Medicine · مجلد 15 (18) · 6992-6992

Purpose: This study aimed to evaluate the effects of active transcranial direct current stimulation (tDCS) compared with sham stimulation on circulating brain-derived neurotrophic factor (BDNF), pain-related outcomes, working memory, and inflammatory and neuroplasticity biomarkers. Methods: PubMed/MEDLINE, Embase, the Cochrane Central Register of Controlled Trials, Web of Science, and ClinicalTrials.gov were searched from inception to May 2026. Randomized and controlled clinical trials comparing active with sham tDCS in adults were included. The primary outcome was post-treatment BDNF concentration. Secondary outcomes included pain intensity, pain catastrophizing, pain-related disability and functional interference, working memory, and circulating inflammatory or neuroplasticity biomarkers. Risk of bias was assessed using the revised Cochrane risk-of-bias tool. Mean differences (MDs) with 95% confidence intervals (CIs) were pooled using random-effects models. Serum and plasma BDNF were analyzed separately. Results: Twenty-one studies were included in the systematic review, of which 15 contributed to at least one quantitative synthesis and 12 study comparisons contributed to the primary BDNF analyses. Active tDCS did not significantly affect serum BDNF (MD = −0.01 [−0.15, 0.13], p = 0.890) or plasma BDNF (MD = 0.02 [−0.25, 0.29], p = 0.870) compared with sham stimulation. In contrast, active tDCS was associated with lower pain intensity (MD = −1.79 [−2.34, −1.23], p < 0.00001). No statistically significant difference was observed in the PCS total score or in the helplessness, magnification, or rumination subscales, although the point estimates generally favored active tDCS. For pain-related disability and functional interference, active tDCS was associated with lower PCP:S total scores and lower emotional interference, whereas no significant differences were observed for interference with daily activities or pain frequency. No significant differences were observed for working memory, interleukins, tumor necrosis factor-alpha, glial cell line-derived neurotrophic factor, interleukin-18, or soluble tumor necrosis factor receptors. Substantial heterogeneity was present in several pain-related and inflammatory biomarker analyses. Conclusions: Active tDCS was not associated with consistent differences in circulating serum or plasma BDNF or in the assessed peripheral inflammatory and neuroplasticity biomarkers compared with sham stimulation; however, these null peripheral findings should not be interpreted as evidence of absent central neuroplastic effects, because circulating measures may not adequately capture localized or transient biological changes within the central nervous system. Active tDCS was associated with improvements in some pain-related outcomes; however, the limited number of studies, substantial heterogeneity, and low certainty of the available evidence preclude firm conclusions regarding its clinical effectiveness for pain management.

transcranial direct current stimulationsham stimulationbrain-derived neurotrophic factorpain intensity
مقالوصول مفتوح2026

Evaluating the efficacy and safety of melatonin for sleep onset insomnia in children aged 6–12: a systematic review and meta-analysis

BMC Pediatrics

Abstract Background Melatonin is an endogenous hormone that regulates the body’s sleep-wake cycles. Due to several clinical trials, it is currently used as an exogenous supplement in pediatric patients who suffer from sleep-onset insomnia (SOI). Consequently, this systematic review and meta-analysis aimed to assess the evidence for the clinical efficacy of melatonin for SOI in children aged 6–12. Methods This systematic review and meta-analysis evaluated the efficacy and safety of Melatonin for sleep-onset insomnia in children aged 6–12 by conducting literature searches in PubMed (97), Google Scholar (111), OVID (33), and Web of Science (156) databases. We performed statistical tests using RevMan for meta-analysis. Heterogeneity was evaluated using the I2 statistic. To maintain the validity of the studies, each included study was assessed by the Cochrane Collaboration Risk of Bias (ROB) tool. The outcomes investigated were sleep onset time (SOT), sleep onset latency (SOL), total sleep time (TST), all-cause dropout rates, and adverse-event dropout rates. Results Three hundred ninety-eight records were identified, and 10 randomized clinical trials met the inclusion criteria. The results demonstrated that melatonin treatment group was associated with an earlier sleep onset time compared with placebo with a mean difference (MD) of -0.48 h (approximately 29 min earlier) (95% confidence interval [CI]: -0.93 to -0.02 h, p = 0.04). The heterogeneity between studies was moderate (I2 = 63%). On the other hand, it was noted that there has been noticed there was a remarkable reduction in sleep onset latency with melatonin compared to placebo, with an MD of -0.38 (95% CI: -0.57 to -0.20, p < 0.0001), with high heterogeneity (I2 = 82%). Conclusion Our study confirmed that melatonin has a marked effect regarding Sleep-onset insomnia in childhood. Therefore, we found there was a statistical and clinical improvement in sleep parameters such as sleep onset time (SOT) and total sleep time (TST) which demonstrated the safety and efficacy of melatonin. However, long-term efficacy and safety need to be addressed, especially in the pediatric population.

melatoninsleep onset insomniapediatric insomniachildren
مقالوصول مفتوح2026

A Systematic Comparative Review of Antipsychotic Efficacy and Safety in the Treatment of Hiccups

Neurosciences · مجلد 31 (3) · 230-243

Objective: To evaluate and compare the safety and effectiveness of antipsychotic medications for the treatment of hiccups, thereby guiding clinicians toward evidence-based treatment guidelines. Hiccups are often benign and self-limiting; however, they can become persistent and intractable, adversely affecting the quality of life. Antipsychotics have been identified as a therapeutic option for the management of hiccups; however, the available evidence supporting their safety and efficacy has not been synthesized. Methods: This review utilized the revised Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The Cochrane Risk of Bias Assessment Tool was modified to evaluate the quality of the selected studies. The search strategy included terms related to or describing hiccups and antipsychotics. Research articles in English published between 1974 and March 2024 were searched in different databases. Duplicates and eligibility criteria were used to screen articles. Results: A search of Medline, Scopus, and Web of Science yielded 1537 articles, of which 1042 were retained after removing duplicates, and 16 met the inclusion criteria. The studies that met the inclusion criteria were all case reports, case series, or retrospective studies, with no randomized trials. A few antipsychotics have been shown to totally or partially alleviate hiccups. Nine studies reported that hiccups were completely resolved in patients treated with 10-25 mg oral and intramuscular chlorpromazine, 1-2 mg oral and intramuscular haloperidol, 2.5-10 mg oral olanzapine, 25-150 mg tetrabenazine, and 3 mg oral risperidone. Adverse events were documented in 7 of the studies. Conclusion: Chlorpromazine and olanzapine are effective antipsychotics for hiccup treatment. However, more evidence-based studies and controlled clinical trials are needed to confirm the efficacy and minimize the side effects. PROSPERO registration: (CRD42024511626).

hiccupsantipsychotic drugschlorpromazinehaloperidol
مقالوصول مفتوح2026

Barriers to women’s access to healthcare in Sudan: insights into male influence and structural constraints

BMC Health Services Research · مجلد 26 (1)

BACKGROUND: Women in Sudan face significant challenges in access to healthcare due to financial hardship, male decision-making influence and geographic limitations, contributing to delayed care-seeking barriers to maternal and reproductive healthcare, and persistent health inequities. METHODOLOGY: A community-based cross-sectional study was conducted among 760 Sudanese women aged 18 years and above using a structured interviewer-administered questionnaire. Data were collected through face-to-face interviews across urban and rural areas, and associations with healthcare accessibility were examined using binary logistic regression analysis. RESULTS: Financial limitations were a major barrier, with 24.8% of women reporting rare or no financial ability to access healthcare. Additionally, 32.1% always required male permission to seek care and 7.6% experienced healthcare delays due to male family members' decisions. Women living more than 10 km from a healthcare facility were 7.1 times more likely to report inadequate access. Nearly half of the participants 49.6% strongly disagreed that male family members understood the importance of timely healthcare. CONCLUSION: Women's access to healthcare in Sudan remains constrained by interconnected economic, sociocultural, and geographic barriers. The findings highlight that urgent policy reforms are needed to expand affordable and geographically accessible healthcare services, strengthen women's financial and decision-making autonomy, and promote community-based interventions that engage men in supportive healthcare practices. CLINICAL TRIAL NUMBER: Not applicable.

women's health care accessSudangender barriersfinancial barriers to care
مقالوصول مفتوح2026

Impact of the BioFire® FilmArray® Gastrointestinal Panel on clinical management of adult acute gastroenteritis: a retrospective analysis from a Saudi tertiary-care setting

BMC Infectious Diseases · مجلد 26 (1)

BACKGROUND: Gastrointestinal Panel (GIP), allow rapid and comprehensive detection of enteric pathogens; however, evidence on their utility from Saudi Arabia is lacking. This study therefore aimed to assess the prevalence of enteric pathogens, determine the detection yield of the FilmArray GIP, and explore its potential impact on clinical management. METHODS: We conducted a retrospective cohort study at Dr. Soliman Fakeeh Hospital, Jeddah, Saudi Arabia, from January 2023 to December 2024. All adult patients (≥ 18 years) with suspected AGE tested using the FilmArray GIP were eligible for inclusion. Clinical and laboratory data, GIP findings, antimicrobial therapy, and clinical outcomes were extracted from electronic medical records. RESULTS: A total of 176 adult patients with AGE were included in this analysis. The FilmArray GIP detected bacterial pathogens in 86.4% of patients, while viral and parasitic agents were identified in 20.5% and 10.2% of the cohort, respectively. Co-detections were observed in 46.6% of patients, although their clinical relevance remains uncertain. Stool microscopy failed to detect any parasitic pathogens, whereas the multiplex panel identified parasites in 18 patients (p < 0.001). Detection of Salmonella was more than five times higher with the FilmArray GIP compared with stool culture (18.2% versus 3.4%; p < 0.001). The FilmArray GIP was associated with antimicrobial modifications, with no antibiotics prescribed in 30.1% of patients, whereas targeted antimicrobials were initiated in 27.3%. Notably, 8.5% of cases required transmission-based isolation, with Clostridioides difficile infections were more frequently associated with isolation compared with norovirus cases (42.3% versus 15.4%; p = 0.11). CONCLUSIONS: The FilmArray GIP demonstrated higher detection yield for enteric pathogens compared with conventional diagnostic techniques. Rapid identification of enteric pathogens was temporally associated with antimicrobial optimization and infection control decisions. Taken together, these findings highlight the potential role of syndromic molecular testing in the management of adult AGE. CLINICAL TRIAL NUMBER: Not applicable.

acute gastroenteritismultiplex PCRenteric pathogensSalmonella
مقالوصول مفتوح2026

Acute effect of whole-body vibration on hand grip strength, muscular activity, and upper limb function in young females with smartphone addiction: a randomized controlled trial

Frontiers in Medicine · مجلد 13 · 1800879-1800879

Objective: To assess the efficacy of whole-body vibration (WBV) on hand grip strength, muscular activity, and upper limb function in young females with smartphone addiction. Materials and methods: This is a single-blinded randomized controlled trial. 66 females aged 18-25 years with smartphone addiction were randomly distributed into two equal groups; WBV group: It received WBV with strengthening exercises, and Sham WBV group: that received Sham WBV plus strengthening exercises. All participants received two sessions per week for four consecutive weeks. The primary outcome was hand grip strength. Secondary outcomes included pinch strength, muscle activity, and upper limb function. Evaluation was performed at baseline and after 4 weeks. Results: < 0.001) compared to the Sham WBV group. Mean differences (95% CI) between both groups were 9.48 [7.07, 11.88] for hand grip strength, which is the primary outcome. Conclusion: WBV combined with hand strengthening exercises might have a positive effect in enhancing hand grip strength, pinch strength, muscle activity, and upper limb function among young females with smartphone addiction. WBV could be a valuable adjunct to traditional rehabilitation programs targeting musculoskeletal effects of smartphone overuse. Clinical trial registration: ClinicalTrials.gov, identifier: NCT06849687.

whole-body vibrationsmartphone addictiongrip strengthpinch strength